The move builds on a steady drumbeat of initiatives by the Fort Wayne-based health system in recent months to increase its brand awareness, services and infrastructure in central Indiana.
At Wednesday’s ribbon cutting, Elanco CEO Jeff Simmons said the new, three-building campus and developing OneHealth Innovation District “will write the history for the next 70 years of Elanco.”
The goal of the National Science Foundation’s Engines program is to grow regional innovation ecosystems.
Eli Lilly and Co. this month launched a public awareness campaign called Brain Health Matters, which features actress Julianne Moore urging people to be proactive as they age to lower their risk of dementia, including Alzheimer’s disease.
Ag giant Corteva Agriscience is reportedly mulling a split of its seed and pesticide businesses, a move that could alter the company’s presence in Indianapolis as well as the state’s agriculture industry.
Ahead of decisions by the FDA, both Novo Nordisk and Eli Lilly are readying production for their weight-loss pills, having been unable to keep up with demand for their shots that exploded in popularity.
The IU Launch Accelerator for Biosciences, or IU LAB, based in Indianapolis, will serve as the coordinating organization for projects launched as part of the initiative.
SIHO Insurance Services is tackling the gargantuan challenge of growth in the employer-based benefits market in Indianapolis and across the state.
The recently established Indy Health District is dedicated to reducing health inequity across Indianapolis. It stretches from St. Clair Street north to 38th Street, encompassing 1,500 acres.
Susan Monarez isn’t “aligned with” President Donald Trump’s agenda and refused to resign as head of the Centers for Disease Control and Prevention, so the White House terminated her, spokesman Kush Desai said Wednesday night.
Over the next two years, Purdue will launch 15 new academic offerings spread between undergraduate and graduate degrees and a few certificate programs.
Indiana Gov. Mike Braun said the agreement “enables Elanco and its partners, including Purdue University, to accelerate the creation of an innovation district in downtown Indianapolis.”
Many patients in their 50s simply want to end chronic joint pain from arthritis, injuries and years of wear and tear to get back to hiking or to take up pickleball.
Elanco Animal Health last week released what CEO Jeff Simmons called its best quarterly earnings since its 2018 spinoff from Eli Lilly and Co.
Trump sent letters to 17 of the world’s largest drugmakers earlier this month, including Lilly and Novo Nordisk A/S, insisting they lower what they charge Medicaid in the U.S. for existing drugs.
The complaint alleges the Indianapolis-based drugmaker offered illegal incentives to influence Texas providers to prescribe Lilly medications including Zepbound and Mounjaro.
Eli Lilly and Co. has already launched LillyDirect service, which CEO David Ricks says jibes with the administration’s demand for direct sales. Lilly is working with Truepill and Amazon.com Inc.’s pharmacy unit on its platform.
The company, which makes vaccines, antibiotics and other animal-health products, said it now expects full-year revenue of between $4.57 billion and $4.62 billion.
The grant will fund a new center at the medical school which will be one of only two in the U.S. dedicated to developing stem-cell-based models of the brain to better understand Alzheimer’s disease.
The University of Indianapolis is launching a program this month to prepare nurse practitioners, long a fixture in primary care exam rooms, to care for complex and critically ill patients in hospitals.
